Literature DB >> 24556720

Identification of a tumor-suppressive human-specific microRNA within the FHIT tumor-suppressor gene.

Baocheng Hu1, Xiaomin Ying, Jian Wang, Jittima Piriyapongsa, I King Jordan, Jipo Sheng, Fang Yu, Po Zhao, Yazhuo Li, Hongyan Wang, Wooi Loon Ng, Shuofeng Hu, Xiang Wang, Chenguang Wang, Xiaofei Zheng, Wuju Li, Walter J Curran, Ya Wang.   

Abstract

Loss or attenuated expression of the tumor-suppressor gene FHIT is associated paradoxically with poor progression of human tumors. Fhit promotes apoptosis and regulates reactive oxygen species; however, the mechanism by which Fhit inhibits tumor growth in animals remains unclear. In this study, we used a multidisciplinary approach based on bioinformatics, small RNA library screening, human tissue analysis, and a xenograft mouse model to identify a novel member of the miR-548 family in the fourth intron of the human FHIT gene. Characterization of this human-specific microRNA illustrates the importance of this class of microRNAs in tumor suppression and may influence interpretation of Fhit action in human cancer. ©2014 AACR.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24556720     DOI: 10.1158/0008-5472.CAN-13-3279

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  24 in total

1.  MiR-548a-3p Promotes Keratinocyte Proliferation Targeting PPP3R1 after Being Induced by IL-22.

Authors:  Xintong Zhao; Ronghua Li; Meng Qiao; Jianjun Yan; Qing Sun
Journal:  Inflammation       Date:  2018-03       Impact factor: 4.092

2.  MiR-501-5p acts as an energetic regulator in head and neck squamous cell carcinoma cells growth and aggressiveness via reducing CLCA4.

Authors:  Bo Li; Yuan-Pei Jiang; Jie Zhu; Lei Meng
Journal:  Mol Biol Rep       Date:  2020-02-19       Impact factor: 2.316

3.  MicroRNA-548j functions as a metastasis promoter in human breast cancer by targeting Tensin1.

Authors:  Yun Zhan; Xiaoshuan Liang; Lin Li; Baona Wang; Fang Ding; Yi Li; Xiang Wang; Qimin Zhan; Zhihua Liu
Journal:  Mol Oncol       Date:  2016-02-23       Impact factor: 6.603

4.  miR-21-mediated Radioresistance Occurs via Promoting Repair of DNA Double Strand Breaks.

Authors:  Baocheng Hu; Xiang Wang; Shuofeng Hu; Xiaomin Ying; Ping Wang; Xiangming Zhang; Jian Wang; Hongyan Wang; Ya Wang
Journal:  J Biol Chem       Date:  2017-01-17       Impact factor: 5.157

5.  Human MicroRNA-548p Decreases Hepatic Apolipoprotein B Secretion and Lipid Synthesis.

Authors:  Liye Zhou; M Mahmood Hussain
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-03-23       Impact factor: 8.311

6.  Growth differentiation factor-15 encodes a novel microRNA 3189 that functions as a potent regulator of cell death.

Authors:  M F Jones; X Ling Li; M Subramanian; Svetlana A Shabalina; T Hara; Y Zhu; J Huang; Y Yang; L M Wakefield; K V Prasanth; A Lal
Journal:  Cell Death Differ       Date:  2015-02-20       Impact factor: 15.828

7.  MicroRNA-548a-5p promotes proliferation and inhibits apoptosis in hepatocellular carcinoma cells by targeting Tg737.

Authors:  Ge Zhao; Ting Wang; Qi-Ke Huang; Meng Pu; Wei Sun; Zhuo-Chao Zhang; Rui Ling; Kai-Shan Tao
Journal:  World J Gastroenterol       Date:  2016-06-21       Impact factor: 5.742

8.  A genomic approach to study down syndrome and cancer inverse comorbidity: untangling the chromosome 21.

Authors:  Jaume Forés-Martos; Raimundo Cervera-Vidal; Enrique Chirivella; Alberto Ramos-Jarero; Joan Climent
Journal:  Front Physiol       Date:  2015-02-04       Impact factor: 4.566

9.  miRNome of inflammatory breast cancer.

Authors:  Diana V Maltseva; Vladimir V Galatenko; Timur R Samatov; Svetlana O Zhikrivetskaya; Nadezhda A Khaustova; Ilya N Nechaev; Maxim U Shkurnikov; Alexey E Lebedev; Irina A Mityakina; Andrey D Kaprin; Udo Schumacher; Alexander G Tonevitsky
Journal:  BMC Res Notes       Date:  2014-12-04

Review 10.  Therapeutic use of microRNAs in lung cancer.

Authors:  Orazio Fortunato; Mattia Boeri; Carla Verri; Massimo Moro; Gabriella Sozzi
Journal:  Biomed Res Int       Date:  2014-09-16       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.